Atopic Dermatitis Models
Atopic dermatitis (AD) is the most common, chronic inflammatory skin disease. To support drug discovery research in this area, WuXi AppTec offers a broad platform of validated, in vivo AD models. Our panel includes DNCB, DNFB, and MC903-induced AD models. Study readouts include histopathology scoring and measurements of serum IgE levels, transepidermal water loss, and mRNA levels of relative cytokines in the skin. Rely on our expertise and leverage our comprehensive platform of AD models now!
Atopic Dermatitis Models
Related Content
Strategies for Novel Autoimmune Drug Development: Preclinical Efficacy and Case Studies of JAK-STAT Targeted Therapies JAK Family Molecules: Central Hubs...
VIEW RESOURCEAccelerating SLE Drug Discovery: A Short-Term BM12-Induced Mouse Model for Efficient Drug Screening Systemic lupus erythematosus (SLE) is a chronic...
VIEW RESOURCE